Forskning
Udskriv Udskriv
Switch language
Region Hovedstaden - en del af Københavns Universitetshospital
Udgivet

Combined measurement of copeptin, high-sensitivity troponin T, and N-terminal proBNP improves the identification of patients at risk of cardiovascular death

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  1. Prevalence of cardiovascular disease and evaluation of standard of care in type 2 diabetes: a nationwide study in primary care

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  2. Fibroblast growth factor 21: new insights from human studies

    Publikation: Bidrag til tidsskriftReviewForskningpeer review

  3. The inflammatory biomarker YKL-40 decreases stepwise after exercise stress test

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  4. Why cholecystokinin and gastrin are also incretins

    Publikation: Bidrag til tidsskriftReviewForskningpeer review

  5. The men who stare at science

    Publikation: Bidrag til tidsskriftTidsskriftartikelFormidling

  1. An atlas of O-linked glycosylation on peptide hormones reveals diverse biological roles

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  2. Cardiac natriuretic peptides

    Publikation: Bidrag til tidsskriftReviewForskningpeer review

  3. Gut Mucosal Gene Expression and Metabolic Changes After Roux-en-Y Gastric Bypass Surgery

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  4. Limited diagnostic utility of Chromogranin A measurements in workup of neuroendocrine tumors

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  5. Distinct non-ischemic myocardial late gadolinium enhancement lesions in patients with type 2 diabetes

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

Vis graf over relationer
Objectives: A multimarker strategy for the handling of patients with heart failure has been suggested in the literature. Therefore, the potential prognostic relevance of combined copeptin, high-sensitivity troponin T (HS-TnT), and N-terminal proBNP (NT-proBNP) measurement in plasma from elderly patients with symptoms of heart failure was evaluated.

Methods: This study included 470 elderly patients (mean age 73 years) from a rural municipality with symptoms of heart failure. Clinical examination, echocardiography, and biomarker measurements were performed. All patients were followed for 13 years and all mortality was registered. Cardiovascular mortality was evaluated using Kaplan–Meier plots and multivariate Cox proportional hazard regression analyses.

Results: Copeptin, HS-TnT, and NT-proBNP measurements provided independent prognostic information in a multivariate setting over 5 years (hazard ratio, HR: 3.66; 95% confidence interval, CI 1.27–10.53, HR: 2.52; 95% CI 1.20–5.28, HR: 2.73; 95% CI 1.19–6.26, respectively). Also, the group with all three biomarkers below cut-off values had a low risk for cardiovascular death (1.8% of the patients in this group died in the 5-year follow-up period). In the 13-year follow-up, combined copeptin and HS-TnT measurement did not provide independent prognostic information.

Conclusion: Combined copeptin, HS-TnT, and NT-proBNP plasma measurements provide prognostic information on cardiovascular mortality that is superior to single biomarker use.

OriginalsprogEngelsk
TidsskriftCardiovascular Endocrinology
Vol/bind1
Udgave nummer4
Sider (fra-til)68-73
DOI
StatusUdgivet - 2012

ID: 36790961